SMAD3 and hepatocellular carcinoma: As shown in Fig. 5d, DYRK1A was coexpressed with TGF-β/SMAD signalling-related genes, such as TGF-β receptor 1, TGF-β receptor 2, SMAD2 and SMAD3, in clinical samples from patients with HCC [32].